Using Artificial Intelligence to determine COVID-19 severity

Using data from China and New York, the new mobile app, which has been developed by researchers NYU College of Dentistry, works to help clinicians identify which COVID-19 patients are most at risk of suffering a high severity of the disease. The Artificial Intelligence (AI) is used to help the clinicians assess the risk factors and identify biomarkers from blood tests. The findings have been published Royal Society of Chemistry journal Lab on a Chip. This new mobile app could be a vital tool in the fight against COVID-19 as current tests only test whether someone does or does not have the virus, not how sick they may become. Lead researcher John McDevitt, professor of biomaterials at NYU College of Dentistry, said: "Identifying and monitoring those at risk for severe cases could help hospitals prioritise care and allocate resources like ICU beds and ventilators. Likewise, knowing who is at low risk for complications could help reduce hospital admissions while these patients are safely managed at home. "We want doctors to have both the information they need, and the infrastructure required to save lives.